Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion type Assertion NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_head.
- NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion wasGeneratedBy ECO_0000203 NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_provenance.
- NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion wasDerivedFrom befree-20150227 NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_provenance.
- NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion SIO_000772 14633710 NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_provenance.
- NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion evidence source_evidence_literature NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_provenance.
- NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_assertion description "[Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482813.RACepQsOmfhRFc-T4rsbzWEP9s7mSYUWajZVQGphfESNg130_provenance.